EarliPoint Health Launches the Developmental Progress Report to Show Change Across Assessments in Autism Care.

Learn More →

Developmental Progress Report

Objective results at intake and every reassessment.

The Developmental Progress Report shows how a child’s EarliPoint results compare with peers, and how those results change from one assessment to the next. Now available to EarliPoint customers.

Sample report. Not patient data.

How it works

From one session to a progress report

Nothing asked beyond watchingRun by trained staff
120+ gaze samples / sec

Where children without autism look at this moment

Latest assessment snapshot

IndexScoreNon-Autism
percentile
Autism
percentile
Clinical category
Social Disability−4.9<5th21stHigh Concern
Language Comprehension736th27thSig. Delayed
Nonverbal Learning10816th38thDelayed

Plus a data quality rating for every session: Excellent, Very Good, or Good.

Qualified clinicianInterprets the results
  • FamilyResults explained by their clinician
  • Care teamGoals for the next period of care
  • PayerProgress, at reauthorization

4 assessments · 1 year 6 months

  1. BaselineBaselineMar 2025Age 3y 0m
  2. ReauthorizationReauth.Sep 2025Age 3y 6m
  3. ReauthorizationReauth.Mar 2026Age 3y 11m
  4. ReauthorizationReauth.Sep 2026Age 4y 6m

Same session, same measurement, every time.

Sample report data. Not patient data.

01 The session

A child watches short videos

The child sits in front of the device and watches short videos of children playing and interacting. A trained staff member runs the session. Nothing is asked of the child beyond watching.

02 What is measured

Where the child looks, moment to moment

Eye-tracking sensors capture more than 120 data points per second while the child watches. Each moment is compared with clinically validated reference data from more than 3,600 assessments.

03 What comes out

Three EarliPoint indices

Results are reported on three indices: Social Disability, Language Comprehension, and Nonverbal Learning. Each comes with a score, peer-sample percentiles, a clinical category, and a data quality rating for the session.

04 Who gets it

A qualified clinician reads it first

Results go to a qualified clinician, who interprets them alongside their own observation, session data, and the tools they already use. From there the report supports the conversations that follow: with the family, the care team, and payers at reauthorization.

05 Next time

The same assessment at every reassessment

Run it at intake to set a baseline, then again ahead of each reauthorization, typically every six months. The child is measured the same way every time, so each result can be read alongside the ones before it.

06 The Developmental Progress Report

Two peer samples, one child

The report places every assessment against age-based reference ranges for a Non-Autism Peer Sample and an Autism Peer Sample. In this sample report, Language Comprehension stays at or below the 6th percentile against non-autism peers, while the same results move from the 11th to the 27th percentile against autism peers.

Sample report. Not patient data.

Inside the report

What the report contains

Latest assessment snapshot

Score, percentile against each peer sample, and clinical category for all three indices.

Assessment history

Every assessment included, with dates, the child’s age at each, and the time span covered.

Reference ranges for each index

Social Disability, Language Comprehension, and Nonverbal Learning, each charted against both peer samples by age.

Data quality for every session

Each assessment is rated Excellent, Very Good, or Good, so results can be read with that in mind.

Looking behavior, visualized

For the latest assessment, where the child looked compared with non-autism looking behavior, linked to skills like joint attention and requesting.

What each index means

A closing page explains each index and who is in each peer sample, written for clinicians and the people they share results with.

What is the Developmental Progress Report?

A report that shows how a child’s EarliPoint results compare with peers and how those results change from one assessment to the next. It covers the three EarliPoint indices, Social Disability, Language Comprehension, and Nonverbal Learning, each against a Non-Autism Peer Sample and an Autism Peer Sample.

No. The DPR is a non-diagnostic report. Qualified clinicians interpret it alongside their own observation and the other information they use. Clinical categories are based on clinical proxy scores; reference range percentiles add peer-group context and may not align directly with clinical categories.

One. A single assessment establishes a baseline. With two or more, the report shows results across assessments over time.

Most ABA providers assess at intake and again ahead of each reauthorization, typically every six months. The timing is the clinician’s call.

Reference ranges come from more than 3,600 clinically validated EarliPoint assessments. For Social Disability, the Non-Autism Peer Sample includes children without autism and some with non-autism developmental delays, and the Autism Peer Sample includes children with autism. For Language Comprehension and Nonverbal Learning, the Non-Autism Peer Sample includes children without autism or developmental delays, and the Autism Peer Sample includes children with autism or developmental delays.

The qualified clinician who ordered the assessment. Clinicians decide how results are shared with families, and they may excerpt the report’s core conclusions into a written evaluation.

Yes. The Developmental Progress Report is available to EarliPoint customers as part of the latest platform release.

See a full sample report

Walk through a Developmental Progress Report page by page with our team, and talk through where it fits in your intake and reauthorization cycle.

  • A sample report, section by section
  • How the two peer samples read together
  • Where it fits in your reassessment schedule

Request a walkthrough

Required fields are marked with an asterisk. Never share sensitive information (credit card numbers, Social Security numbers, passwords) through this form.

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder